About MoleculeDx
Building on peer-reviewed fusion-gene research to explore molecular information associated with cancer.
Our purpose
MoleculeDx advances research-based molecular approaches to liver cancer screening, focused on cancer-associated cell-free fusion gene signals in blood. Our goal is to make molecular testing accessible while supporting informed, physician-guided follow-up.
Scientific foundation
The approach draws from research on fusion genes, circulating fusion transcripts and multi-marker statistical models in hepatocellular carcinoma. Published research includes studies in Oncotarget (2019) and The American Journal of Pathology (2024).
What we believe
Patients and clinicians deserve clear communication about the distinction between promising research evidence, a screening result, and a clinical diagnosis.
Ready to learn more?
Discuss appropriate HCC surveillance with your healthcare professional. Start an order through the secure MoleculeDx booking portal.